J. Andrew Johnston, PharmD
- 4Articles
- 14.3KReads1
- 1997–2005Active
- 14Collaborators
- 161Citations2
About
J. Andrew Johnston, PharmD, has authored multiple articles on the clinical use and safety of bupropion formulations in the treatment of major depressive disorder. Publications span from 1997 to 2005 and include topics such as comparative studies between bupropion and sertraline, therapy discontinuation, and long-term clinical experience with various bupropion formulations. Johnston's work contributes to the psychiatry field with a focus on antidepressant pharmacotherapy.
Publications
1 Read counts for articles published before 2020 may include some non-human traffic.
2 Citation counts provided by Crossref.
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
